BioGenes Berlin

What’s New at BioGenes

Are you interested in the latest news, trends and events regarding antibodies, custom ELISAs and HCP? Then you have come to the right spot.

The BioGenes team is happy to present you with the latest and most interesting topics in our news & trends blog. Please use the filter option on the right to find specific topics of choice. 

Is there any feedback that you would like to share with us? In that case please contact us.



Meet BioGenes at These Events

Meet our team at the following events this year to discuss your latest projects and questions. We look forward to meeting you!



New: BioGenes HEK293 HCP ELISA Kits

After thorough development and testing, we can finally announce the start of a new BioGenes HCP product: The HEK293|360 HCP ELISA kits is now…



New Tech Note: How to Overcome Cross Reactivity Towards Drug Substances

Discover the insights shared at the 11th annual BEBPA Host Cell Protein Conference held in Dubrovnik, Croatia. The conference featured a plethora of…



BioGenes is Your Reliable Partner for Contract Manufacturing

Did you know? BioGenes is not only an expert for antibody development and HCP assays, but also offers contract immunoassay production…


Q & A

Q&A: How should the optimal mock material for anti-HCP antibody generation be prepared?


The most important step for specific HCP ELISA development is the production of suitable mock material, which is used as HCP antigen for…



New Webinar: "Strategies for Successful HCP Monitoring"

In this webinar, Charlotte Coenders, Business Development Manager at BioGenes, will showcase BioGenes' approach to HCP monitoring and how our…


Q & A

Q&A: How are process-specific Host Cell Protein ELISAs developed at BioGenes?

Answer: Generic kits are broadly used for the measurement of HCPs in biologicals during the downstream process. However, for the later stages, process…


Q & A

Q&A: How to decide which generic HCP ELISA type is suitable for HCP monitoring in my biological drug manufacturing process?

Answer: We recommend working with generic ELISA kits during early drug development phases. The proteins of host cells are specific for a given process…



We are celebrating 30 Years of BioGenes

This summer, BioGenes is turning 30 and our celebrations would not be complete without you!

Thank you for being a part of our journey and for making…


Q & A

Q&A: How are generic ELISA kits developed and what is special about the BioGenes 360 approach?

Answer: The development of generic HCP ELISA kits involves the following steps:

  • Immunization of individuals using a particular antigen material
  • Isolat…


Keep me updated